Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
87,487,000
-
Total 13F shares
-
85,919,846
-
Share change
-
+57,015,275
-
Total reported value
-
$343,681,474
-
Price per share
-
$4.00
-
Number of holders
-
75
-
Value change
-
+$228,817,038
-
Number of buys
-
53
-
Number of sells
-
11
Institutional Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) as of Q4 2025
As of 31 Dec 2025,
X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,919,846 shares.
The largest 10 holders included
Empery Asset Management, LP, FMR LLC, MORGAN STANLEY, Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, Saturn V Capital Management LP, Deep Track Capital, LP, Kalehua Capital Management LLC, VANGUARD GROUP INC, and BRAIDWELL LP.
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.